News
Live Science on MSN1d
Common gut microbe shows promise as fatty liver disease treatmentResearchers shed light on the "dark matter" of the gut, revealing a species of fungus that could potentially help counter ...
Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has demonstrated sustained efficacy in a late-stage trial of patients with ...
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
GSK will gain access to efimosfermin by acquiring Boston’s subsidiary BP Asset IX for $1.2bn upfront and up to $800m in ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback